BS Nursing Epidemiology
nmdcat.online June 6, 2026

33. A pharmaceutical company is developing a new drug for a chronic condition. During which medicinal phase of clinical trials are the potential side effects and optimal dosage ranges typically determined in a small group of healthy volunteers?

A. Phase I.
B. Phase II.
C. Phase III.
D. Phase IV.

📖 Additional Information

  • Phase I.
  • Phase II.
  • Phase III.
  • Phase IV.

🔗 Share This Question

Categories

View all →